Shenzhen Neptunus Interlong Bio-technique Company Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 215.7 million compared to CNY 219.29 million a year ago. Net income was CNY 10.54 million compared to CNY 15.65 million a year ago. Basic earnings per share from continuing operations was CNY 0.0063 compared to CNY 0.0093 a year ago.